title: IGF1 dependence of dietary energy balance effects on murine Met1 mammary tumor progression, epithelial-to-mesenchymal transition, and chemokine expression.
abstract: Luminal breast tumors with little or no estrogen receptor α expression confer poor prognosis. Using the Met1 murine model of luminal breast cancer, we characterized the IGF1-dependency of diet-induced obesity (DIO) and calorie restriction (CR) effects on tumor growth, growth factor signaling, epithelial-to-mesenchymal transition (EMT), and chemokine expression. Liver-specific IGF1-deficient (LID) and littermate control (LC) mice were administered control, DIO, or 30% CR diets for 3 months before orthotopic injection of Met1 cells. Tumors grew for 1 month and then were assessed for Akt pathway activation and mRNA expression of chemokine and EMT constituents. LID mice, regardless of diet, displayed reduced Met1 tumor growth and downregulated Akt, EMT, and chemokine pathways. CR, relative to control, reduced serum IGF1 and Met1 tumor growth in LC (but not LID) mice. DIO, relative to control, increased Met1 tumor growth and chemokine expression in LID mice, and had no effect on serum IGF1 or pAkt or cyclin D1 expression in either genotype. Thus, circulating IGF1 (in association with Akt, EMT, and chemokines) regulated Met1 tumor growth. While the anticancer effects of CR were largely IGF1-dependent, the procancer effects of DIO manifested only when circulating IGF1 levels were low. Thus, in a murine model of luminal breast cancer, IGF1 and its downstream signaling pathway, EMT, and chemokines present possible mechanistic regulatory targets. Transplanted MMTV1 Wnt1 mammary tumor growth was also reduced in LID mice, relative to LC mice, suggesting that the IGF1 effects on mammary tumor growth are not limited to Met1 tumors.
authors.affiliation: Department of Nutritional Sciences, Dell Pediatric Research Institute, University of Texas, Austin, 78722, USA.
authors.forename: Nikki A
authors.initials: NA
authors.lastname: Ford
authors.forename: Nomeli P
authors.initials: NP
authors.lastname: Nunez
authors.forename: Valerie B
authors.initials: VB
authors.lastname: Holcomb
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Hursting
mesh_terms: D000818:Animals; D031204:Caloric Restriction; D018925:Chemokines / Q000235:genetics / Q000378:metabolism*; D004032:Diet; D018450:Disease Progression; D004734:Energy Metabolism; D058750:Epithelial-Mesenchymal Transition; D005260:Female; D006728:Hormones / Q000097:blood; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D015674:Mammary Neoplasms, Animal / Q000150:complications / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D018345:Mice, Knockout; D009765:Obesity / Q000209:etiology / Q000378:metabolism / Q000473:pathology; D010766:Phosphorylation; D051057:Proto-Oncogene Proteins c-akt / Q000235:genetics / Q000378:metabolism; D019859:Proto-Oncogene Proteins c-met / Q000502:physiology*; D012333:RNA, Messenger / Q000235:genetics; D060888:Real-Time Polymerase Chain Reaction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction; D047368:Tumor Burden
chemical_list: D018925:Chemokines; D006728:Hormones; D012333:RNA, Messenger; D007334:Insulin-Like Growth Factor I; D019859:Proto-Oncogene Proteins c-met; D051057:Proto-Oncogene Proteins c-akt